European shares start week on firm footing, vaccine developments eyed
Shares of insurers, banks and automakers climbed more than 1% in early trading.
- Country:
- Australia
European shares rebounded on Monday after a Wall Street-led rout in technology stocks kept global sentiment subdued in the previous week, with investors keeping a close watch on COVID-19 vaccine developments.
Australia expects to receive its first batches of a potential COVID-19 vaccine in January after a deal was struck with CSL to manufacture two vaccines - one developed by rival AstraZeneca and Oxford University, and another in CSL's own labs with the University of Queensland. AstraZeneca rose 1.5%. The European healthcare sector index jumped 0.9%.
The STOXX 600 index was 0.8% higher by 0709 GMT, with Frankfurt shares leading gains after rising 1%. Shares of insurers, banks and automakers climbed more than 1% in early trading.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
BRIEF-Astrazeneca To Increase 2024 Dividend By 7%
BRIEF-Astrazeneca Says All Resolutions Were Supported At Today's AGM
AstraZeneca shareholders approve 2024 pay policy at AGM
AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot
Headline: Empowering Professionals with In-Demand Skills: Oxford University Press and NSE Academy Join Forces to Offer Certificate Courses